# EDWARDS LIFESCIENCES CORPORATION (EW) FY2025 Annual Balance Sheet

- Company: EDWARDS LIFESCIENCES CORPORATION (EW)
- Period: As of 2025-12-31
- Filing: FY2025 10-K, filed 2026-02-25, accession number 0001099800-26-000009
- Page: https://plicit.ai/financials/ew/fy2025-annual-balance-sheet
- Chart image: https://plicit.ai/charts/ew-fy2025-annual-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2025-12-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 13,697,200,000 US dollars
- **Current assets**: 6,738,900,000 US dollars
- **Non-current assets**: 6,958,300,000 US dollars
- **Liabilities**: 3,359,600,000 US dollars
- **Current liabilities**: 1,813,700,000 US dollars
- **Non-current liabilities**: 1,545,900,000 US dollars
- **Equity**: 10,337,600,000 US dollars
- **Noncontrolling interest**: 0 US dollars. Included in consolidated equity; this amount is not added again.
- **Cash and cash equivalents**: 2,938,000,000 US dollars
- **Short-term investments (Note 8)**: 1,288,300,000 US dollars
- **Inventories (Note 6)**: 1,126,200,000 US dollars
- **Accounts receivable, net of allowances of $15.0 and $11.6, respectively**: 659,600,000 US dollars
- **Other current assets**: 339,300,000 US dollars
- **Other receivables**: 252,500,000 US dollars
- **Prepaid expenses**: 135,000,000 US dollars
- **Current assets of discontinued operations (Note 5)**: 0 US dollars
- **Property, plant, and equipment, net (Note 6)**: 1,811,900,000 US dollars
- **Goodwill (Note 11)**: 1,768,600,000 US dollars
- **Deferred income taxes**: 1,138,100,000 US dollars
- **Other intangible assets, net (Note 11)**: 1,128,200,000 US dollars
- **Other assets**: 730,200,000 US dollars
- **Long-term investments (Note 8)**: 278,600,000 US dollars
- **Operating lease right-of-use assets (Note 7)**: 102,700,000 US dollars
- **Non-current assets of discontinued operations (Note 5)**: 0 US dollars
- **Accrued and other liabilities (Note 6)**: 1,561,700,000 US dollars
- **Accounts payable**: 227,500,000 US dollars
- **Operating lease liabilities (Note 7)**: 24,500,000 US dollars
- **Current liabilities of discontinued operations (Note 5)**: 0 US dollars
- **Long-term debt (Note 12)**: 598,300,000 US dollars
- **Uncertain tax positions (Note 19)**: 502,700,000 US dollars
- **Other liabilities**: 362,300,000 US dollars
- **Operating lease liabilities (Note 7)**: 82,600,000 US dollars
- **Litigation settlement accrual**: 0 US dollars
- **Retained earnings**: 14,240,500,000 US dollars
- **Additional paid-in capital**: 2,768,400,000 US dollars
- **Common stock, $1.00 par value, 1,050.0 shares authorized, 658.7 and 654.8 shares issued, and 580.7 and 588.6 shares outstanding, respectively**: 658,700,000 US dollars
- **Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding**: 0 US dollars
- **Noncontrolling interest (Note 9)**: 0 US dollars
- **Treasury stock, at cost, 78.0 and 66.2 shares, respectively**: negative 7,091,700,000 US dollars
- **Accumulated other comprehensive loss (Note 17)**: negative 238,300,000 US dollars
- **Gross equity (calculated)**: 17,667,600,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.